Skip to main content

Table 3 HPV Genotype distribution in 1265 SurePath screening samples and 1249 ThinPrep screening samples tested with Genomica CLART4S and MGP-PCR

From: Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening

HPV genotypes Prevalence Agreement (CLART4S/MGP-PCR) Kappa McNemar
CLART4S MGP-PCR Ratio +/+ +/− −/+ −/− Agreement
SurePatha
 16 41 44 0.93 40 1 4 1220 99.6 0.94 0.38
 18 10 11 0.91 9 1 2 1253 99.8 0.86 1.00
 31 33 32 1.03 31 2 1 1231 99.8 0.95 1.00
 33 11 7 1.57 7 4 0 1254 99.7 0.78 0.13
 35 7 6 1.17 5 1 2 1257 99.8 0.77 1.00
 39 20 13 1.54 10 10 3 1242 99.0 0.60 0.09
 45 20 27 0.74 19 1 8 1237 99.3 0.81 0.04
 51 10 7 1.43 6 4 1 1254 99.6 0.70 0.34
 52 24 24 1.00 20 4 4 1237 99.4 0.83 1.00
 56 12 11 1.09 10 1 2 1252 99.8 0.87 1.00
 58 15 7 2.14 7 8 0 1250 99.4 0.63 0.01
 59 10 11 0.91 8 2 3 1252 99.6 0.76 1.00
 66 5 12 0.42 4 1 8 1252 99.3 0.47 0.04
 68 14 8 1.75 3 11 5 1246 98.7 0.27 0.21
 14 Hr-HPV 185 181 1.02 156 29 25 1055 95.7 0.83 0.68
ThinPrepb
 16 47 82 0.57 47 0 35 1167 96.0 0.72 0.00
 18 9 12 0.75 9 0 3 1237 98.5 0.86 0.05
 31 29 40 0.73 29 0 11 1209 97.9 0.84 0.00
 33 20 18 1.11 17 3 1 1228 98.4 0.89 0.63
 35 8 8 1.00 6 2 2 1239 98.4 0.75 1.00
 39 3 9 0.33 3 0 6 1240 98,3 0.50 0.03
 45 9 16 0.56 9 0 7 1233 98.2 0.69 0.02
 51 14 23 0.61 13 1 10 1225 97.9 0.70 0.01
 52 12 25 0.48 12 0 13 1224 97.7 0.64 0.00
 56 4 8 0.50 4 0 4 1241 98.4 0.67 0.13
 58 12 15 0.80 11 1 4 1233 98.3 0.81 0.38
 59 2 10 0.20 2 0 8 1239 98.1 0.33 0.01
 66 0 15 0.00 0 0 15 1234 97.5 0.00 0.00
 68 9 10 0.90 4 5 6 1234 97.9 0.42 1.00
 14 Hr-HPV 151 236 0.64 147 4 89 1009 91.4 0.72 0.00
  1. aData for both Control (1184) and Case (81) SurePath screening samples. In total 1265 SurePath samples
  2. bDato for both Control (1169) and Case (80) ThinPrep screening samples. In total 1249 ThinPrep samples